First open-label, randomized, crossover, inpatient pharmacokinetic phase I study of Naloxone (Intranasal and Intramuscular) in healthy adult volunteers.

Trial Profile

First open-label, randomized, crossover, inpatient pharmacokinetic phase I study of Naloxone (Intranasal and Intramuscular) in healthy adult volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs Naloxone (Primary) ; Naloxone (Primary)
  • Indications Drug abuse
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Mar 2017 Results published in an Opiant Pharmaceuticals media release.
    • 08 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top